Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-03

Clinical Trial Update: E4/DRSP Ovarian Function Inhibition Study [Phase 2]

View source ↗

Summary

Phase 2 trial of E4/DRSP for prevention of pregnancy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • E4/DRSP (ethinyl estradiol / drospirenone)

Snippet

Sponsor: Estetra | Conditions: Prevention of Pregnancy | Phase 2 | Status: COMPLETED